Cargando…
Establishing a novel and sensitive assay for bioactivity determination of anti-CD25 antibodies
Anti-CD25 antibodies have been approved for renal transplantation and has been used prior to and during transplantation by the Food and Drug Administration (FDA). However, no reported bioassays have been reflected the mechanism of action (MOA) of anti-CD25 antibodies. Here, we describe the developme...
Autores principales: | Duan, Maoqin, Yu, Chuanfei, Yang, Yalan, Fu, Zhihao, Liu, Chunyu, Du, Jialiang, Li, Meng, Guo, Sha, Yu, XiaoJuan, Xu, Gangling, Mei, Yuting, Wang, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320283/ https://www.ncbi.nlm.nih.gov/pubmed/37416689 http://dx.doi.org/10.1016/j.heliyon.2023.e17401 |
Ejemplares similares
-
Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells
por: Xu, Gangling, et al.
Publicado: (2021) -
Method validation of a bridging immunoassay in combination with acid-dissociation and bead treatment for detection of anti-drug antibody
por: Du, Jialiang, et al.
Publicado: (2023) -
A reporter gene assay for determining the biological activity of therapeutic antibodies targeting TIGIT
por: Fu, Zhihao, et al.
Publicado: (2021) -
Fingerprinting trimeric SARS-CoV-2 RBD by capillary isoelectric focusing with whole-column imaging detection
por: Du, Jialiang, et al.
Publicado: (2023) -
A simple and robust reporter gene assay for measuring the bioactivity of anti-RANKL therapeutic antibodies
por: Yu, Chuanfei, et al.
Publicado: (2019)